Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study on the Treatment of Advanced Non-small Cell Lung Cancer With Brain Metastasis by SRS Sequential Sintilimab

NCT04180501 is registered in ClinicalTrials.gov with Xiaorong Dong as lead sponsor.

NCT NCT04180501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04180501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study on the Treatment of Advanced Non-small Cell Lung Cancer With Brain Metastasis by SRS Sequential Sintilimab
Lead sponsor
Xiaorong Dong
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2019
Completion date
December 31, 2021
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, nsclc stage iv, sintilimab, srs